Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maja Rothenberg-Thurley

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
The Journal of Molecular Diagnostics : JMD|May 21, 2021
Double Drop-Off Droplet Digital PCR: A Novel, Versatile Tool for Mutation Screening and Residual Disease Monitoring in Acute Myeloid Leukemia Using Cellular or Cell-Free DNAChristian Rausch, Maja Rothenberg-Thurley, Simon A Buerger, et al.
Haematologica|April 6, 2019
Response assessment in acute myeloid leukemia by flow cytometry supersedes cytomorphology at time of aplasia, amends cases without molecular residual disease marker and serves as an independent prognostic marker at time of aplasia and post-inductionThomas Köhnke, Veit Bücklein, Sandra Rechkemmer, et al.
Iscience|December 4, 2023
Modeling early treatment response in AML from cell-free tumor DNADantong Wang, Christian Rausch, Simon A Buerger, et al.
Blood Advances|September 14, 2019
Patients with spontaneous remission of high-risk MDS and AML show persistent preleukemic clonal hematopoiesisVictoria V Grunwald, Marcus Hentrich, Xaver Schiel, et al.
Haematologica|December 1, 2020
Plasticity in growth behavior of patients' acute myeloid leukemia stem cells growing in miceSarah Ebinger, Christina Zeller, Michela Carlet, et al.
Blood|October 18, 2022
WT1 and DNMT3A play essential roles in the growth of certain patient AML cells in miceMaryam Ghalandary, Yuqiao Gao, Diana Amend, et al.
Iscience|July 31, 2023
Progressive disruption of hematopoietic architecture from clonal hematopoiesis to MDSMichèle C Buck, Lisa Bast, Judith S Hecker, et al.
Leukemia|April 11, 2023
Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemiaChristian Rausch, Maja Rothenberg-Thurley, Annika Dufour, et al.
Blood Advances|February 4, 2025
Pretransplant MRD does not seem to affect survival in NPM1-mutated AML undergoing allogeneic stem cell transplantationAlessia Fraccaroli, Vindi Jurinovic, Klaus Hirschbühl, et al.
Cancer|October 22, 2022
Molecular profiling of patients with cytogenetically normal acute myeloid leukemia and hyperleukocytosisFriederike Pastore, Alessandro Pastore, Maja Rothenberg-Thurley, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
The Journal of Molecular Diagnostics : JMD|May 21, 2021
Double Drop-Off Droplet Digital PCR: A Novel, Versatile Tool for Mutation Screening and Residual Disease Monitoring in Acute Myeloid Leukemia Using Cellular or Cell-Free DNAChristian Rausch, Maja Rothenberg-Thurley, Simon A Buerger, et al.
Haematologica|April 6, 2019
Response assessment in acute myeloid leukemia by flow cytometry supersedes cytomorphology at time of aplasia, amends cases without molecular residual disease marker and serves as an independent prognostic marker at time of aplasia and post-inductionThomas Köhnke, Veit Bücklein, Sandra Rechkemmer, et al.
Iscience|December 4, 2023
Modeling early treatment response in AML from cell-free tumor DNADantong Wang, Christian Rausch, Simon A Buerger, et al.
Blood Advances|September 14, 2019
Patients with spontaneous remission of high-risk MDS and AML show persistent preleukemic clonal hematopoiesisVictoria V Grunwald, Marcus Hentrich, Xaver Schiel, et al.
Haematologica|December 1, 2020
Plasticity in growth behavior of patients' acute myeloid leukemia stem cells growing in miceSarah Ebinger, Christina Zeller, Michela Carlet, et al.
Blood|October 18, 2022
WT1 and DNMT3A play essential roles in the growth of certain patient AML cells in miceMaryam Ghalandary, Yuqiao Gao, Diana Amend, et al.
Iscience|July 31, 2023
Progressive disruption of hematopoietic architecture from clonal hematopoiesis to MDSMichèle C Buck, Lisa Bast, Judith S Hecker, et al.
Leukemia|April 11, 2023
Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemiaChristian Rausch, Maja Rothenberg-Thurley, Annika Dufour, et al.
Blood Advances|February 4, 2025
Pretransplant MRD does not seem to affect survival in NPM1-mutated AML undergoing allogeneic stem cell transplantationAlessia Fraccaroli, Vindi Jurinovic, Klaus Hirschbühl, et al.
Cancer|October 22, 2022
Molecular profiling of patients with cytogenetically normal acute myeloid leukemia and hyperleukocytosisFriederike Pastore, Alessandro Pastore, Maja Rothenberg-Thurley, et al.
Pageof 4